Lealto Consulting
Clinical trial regulatory, scientific and operational consulting for pharmaceutical, biotech and research organizations
Highlights
- Young companyFounded 2024
- New on EvolcAdded 2026-11-09
About Lealto Consulting
Lealto Consulting provides regulatory strategy, clinical science, trial design, operational support and medical writing for early-phase clinical development. Services include support with trial protocols, regulatory submissions and study reports.
The consultancy serves pharmaceutical and biotechnology companies, contract research organisations and clinical research institutions. It was founded in 2024 by Dr Sally Dowen and is based in Bexhill-on-Sea, United Kingdom.
Product: Consulting and medical writing services for early-phase clinical trials, including regulatory strategy, clinical science, trial design and operational support.
Jobs at Lealto Consulting
Leadership
- Sally Dowen · FounderSource: company website
More biotech & pharma companies
Levicept
Develops a non-opioid biologic treatment for osteoarthritis pain for patients with painful joint diseaseNew on EvolcLGC Group
Reference materials, diagnostic quality controls and analytical standards for labs and life-science companiesLibero Pharma
Develops transdermal naltrexone patches for patients with addiction, fibromyalgia and Crohn’s diseaseNew on EvolcLife Research Oxford
Develops sperm DNA epigenetic assays and fertility tests for reproductive medicine researchers and clinical usersYoung companyNew on EvolcLife Science Group
Manufactures life science reagents and custom liquids for research, diagnostic and bioprocessing customersNew on EvolcLift Therapeutics
Develops neutrophil-based cell immunotherapies for patients with hard-to-treat solid cancersNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content management
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.
